MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    String Vessel Formation Regionally Increases in Long Duration Parkinson’s Disease

    D. Dik, GM. Halliday, V. Sytnyk, C. Shepherd (Randwick, Australia)

    Objective: Parkinson's disease is a movement disorder characterised by α-synuclein deposition in the form of Lewy bodies and Lewy neurites. Vascular changes have been thought to contribute…
  • 2024 International Congress

    Quantitative Assessment of X-linked Dystonia-Parkinsonism Using Wearable Sensing Technology

    G. Corniani, G. Del Duca, S. Sanseverino, N. Ganza, S. Begalan, C. Nelson, P. Acuna, C. Go, N. Sharma, P. Bonato, C. Stephen (Boston, USA)

    Objective: To create a quantitative, objective framework for assessing combined dystonia parkinsonism using kinematic data from wearable sensors combined with machine learning (ML), enabling clinician-independent…
  • 2024 International Congress

    Clinical Utility of Synuclein Skin Biopsy in the Initial Diagnosis and Evaluation of Parkinsonian Disorders

    J. Isaacson, R. Freeman, C. Gibbons, A. Alshehri (Boston, USA)

    Objective: To determine the clinical utility of phosphorylated alpha-synuclein (P-SYN) within skin biopsies in diagnostic and management decisions. Background: The initial diagnosis of Parkinson’s Disease…
  • 2024 International Congress

    Multifaceted Challenges in Multisystem Atrophy Management: Medication Sensitivity, Emotional Lability, and Increased Fall Risk

    G. Legerme, B. Carr, C. Rowan (Gainesville, USA)

    Objective: Multisystem atrophy (MSA) epitomizes a formidable quandary within neurological and geriatric disciplines, delineated by complex manifestations encompassing autonomic dysfunction, parkinsonism, and cerebellar ataxia. This…
  • 2024 International Congress

    New onset movement disorders following COVID-19 infection

    D. van Wamelen, B. Facer, S. Rota, M. Bonello, K. Chaudhuri, G. Breen, B. Michael (London, United Kingdom)

    Objective: To determine the prevalence and phenotype of movement disorders following SARS-CoV-2 infection in hospitalised individuals. Background: Although movement disorders, including parkinsonism, following SARS-CoV-2 (COVID-19)…
  • 2024 International Congress

    Hydrocephalic Progressive Supranuclear Palsy: An Underrecognized Entity

    A. Premkumar, D. Lim, SK. Seetharaman, LF. Tan (Singapore, Singapore)

    Objective: We describe a case of NPH-like presentation of PSP, review literature surrounding this entity, and discuss key diagnostic considerations and implications. Background: Despite advances…
  • 2024 International Congress

    Vestibular impairment, turning direction and turn progression in Parkinson’s disease

    C. Pongmala, M. van Emde-Boas, P. Kanel, N. Bohnen (Ann Arbor, USA)

    Objective: To explore the correlation between the Romberg test condition 4 and turn progression in most affected and least affected body side directions in people…
  • 2024 International Congress

    Association between Antiepileptic Drugs and Parkinson’s Disease: A Strong or Weak Link?

    S. Kharel, SS. Shrestha, SA. Acharya, R. Ojha (Kathmandu, Nepal)

    Objective: To perform a meta-analysis to show the association between different Antiepileptic Drugs(AEDs) and Parkinson’s disease(PD). Background: PD is a neurodegenerative disorder affecting 1-2% of…
  • 2024 International Congress

    α-Synuclein Pathology Across Movement Disorders and Neurodegenerative Diseases by Seed Amplification Assay

    S. Weber, C. Farris, Y. Ma, M. Dakna, M. Starke, C. Trenkwalder, L. Concha-Marambio, B. Mollenhauer (Goettingen, Germany)

    Objective: To assess the frequency of pathological α-synuclein (αSyn) in various movement disorders and neurodegenerative diseases from a specialized movement disorder clinic by αSyn seed…
  • 2024 International Congress

    TOPAS-MSA: Targeting Oligomer Pathology of Alpha-Synuclein – A Study Evaluating the Safety and Efficacy of Emrusolmin in Patients with Multiple System Atrophy

    J. Levin, T. Matthias, H. Knebel, S. Barash, L. Marinelli, A. Ahn, A. Giese, M. Chen, J. Nettleship ()

    Objective: The objective of the TOPAS-MSA study is to assess the safety and efficacy of emrusolmin (anle138b/TEV-56286), an orally bioavailable small molecule targeting aggregated α-synuclein,…
  • « Previous Page
  • 1
  • …
  • 105
  • 106
  • 107
  • 108
  • 109
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley